Drug-induced Vasculitis in a Breast Cancer Patient Receiving Chemotherapy


Shapour Omidvari 1 , Hamid Nasrolahi 1 , * , Seyed Ahmad Javid 2 , Seyed Hasan Hamedi 1 , Mohammad Mohammadianpanah 3 , Mansour Ansari 1 , Niloofar Ahmadloo 1 , Ahmad Mosalaei 4

1 Department of Radiation Oncology, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran

2 Dr. Javid Laboratory, Shiraz, Iran

3 Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

4 Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences, Shiraz, Iran

How to Cite: Omidvari S, Nasrolahi H, Javid S A, Hamedi S H, Mohammadianpanah M, et al. Drug-induced Vasculitis in a Breast Cancer Patient Receiving Chemotherapy, Rep Radiother Oncol. 2013 ; 1(2):e2390.


Reports of Radiotherapy and Oncology: 1 (2); 81-4
Published Online: September 01, 2013
Article Type: Case Report
Received: July 01, 2013
Accepted: August 07, 2013




Introduction: Drug-induced vasculitis following chemotherapy has been rarely reported. We report such a case of drug-induced vasculitis following chemotherapy in a breast cancer patient.

Report of the case:  A 52 year old woman with stage III breast cancer developed pathologically proven vasculitis presenting as bilateral severe erythema, edema and ulceration on both feet 10 days following the 4th cycle of adjuvant chemotherapy.  Chemotherapy consisted of docetaxel, doxorubicin, and cyclophosphamide in each cycle that was preceded by premedication including dexamethasone, granisetron, and H1 and H2 blockers. Furthermore, filgrastim (5µg/kg) was administered following each cycle of chemotherapy during days 5-9. By discontinuing chemotherapy and starting high-dose intravenous methylprednisolone, vasculitis was resolved. The patient did not experience vasculitis following the re-challenge of chemotherapy excluding docetaxel and filgrastim.

Conclusion: This case suggests that docetaxel and filgrastim might be added to the list of agents causing drug-induced vasculitis.


Drug-induced vasculitis docetaxel filgrastim breast cancer

© 0, Reports of Radiotherapy and Oncology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.


Full text is available in the PDF.


  • 1.

    References are available in the PDF.